Choi Seong Ji, Choi Hyuk Soon
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Gastrointestinal Medical Instrument Research, Korea University College of Medicine, Seoul, Korea.
Clin Endosc. 2018 Sep;51(5):407-415. doi: 10.5946/ce.2018.140. Epub 2018 Sep 27.
Obesity is a chronic disease with an exponentially increasing incidence rate, and its negative effects are well documented in numerous studies. As a result, the importance of bariatric therapy cannot be overemphasized, and many bariatric treatment methods with varying mechanisms have been developed. Of the available treatment methods, intragastric balloons, introduced in the 1980s, have been shown to be a safe and effective treatment modality; various intragastric balloon products have been developed and are currently being widely used in clinical settings. However, the disadvantages of intragastric balloons, such as unclear long-term weight loss benefits and complications experienced during insertion and removal, preclude their wider use. In this review, we discuss different intragastric balloon products, focusing on those under clinical investigation, and suggest future research directions.
肥胖是一种发病率呈指数级增长的慢性疾病,其负面影响在众多研究中已有充分记录。因此,减重治疗的重要性再怎么强调也不为过,并且已经开发出了许多机制各异的减重治疗方法。在现有的治疗方法中,20世纪80年代引入的胃内球囊已被证明是一种安全有效的治疗方式;各种胃内球囊产品已经开发出来,目前正在临床环境中广泛使用。然而,胃内球囊的缺点,如长期减重效果不明确以及插入和取出过程中出现的并发症,限制了它们的更广泛应用。在这篇综述中,我们讨论了不同的胃内球囊产品,重点关注那些正在进行临床研究的产品,并提出了未来的研究方向。